Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C

AIM: To evaluate interferon-λ3 (IFNL3) polymorphisms in response-guided pegylated interferon-α plus ribavirin (Peg-IFNα/RBV) therapy for genotype 2 (G2) chronic hepatitis C. METHODS: Between January 2006 and June 2012, a total of 180 patients with chronic infections of G2 hepatitis C virus (HCV) wer...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:World J Gastroenterol
Main Authors: Ishiguro, Haruya, Abe, Hiroshi, Seki, Nobuyoshi, Sugita, Tomonori, Aida, Yuta, Itagaki, Munenori, Sutoh, Satoshi, Shimada, Noritomo, Furihata, Tomomi, Tsubota, Akihito, Aizawa, Yoshio
Formato: Artigo
Idioma:Inglês
Publicado: Baishideng Publishing Group Inc 2015
Assuntos:
Case Control Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4385537/
https://ncbi.nlm.nih.gov/pubmed/25852275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i13.3904
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares